Marshall Wace’s Immune Design Corp. IMDZ Stock Holding History

Marshall Wace’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,298	Closed	-$36K	–	1962
2018 Q3	$36K	Buy	+10,298	New	+$38.7K	﹤0.01%	1110
2016 Q2	–	Sell	-76,145	Closed	-$990K	–	1326
2016 Q1	$990K	Buy	76,145 +3,333	+5%	+$38.5K	0.01%	718
2015 Q4	$1.46M	Hold	72,812	–	–	0.01%	619
2015 Q3	$888K	Hold	72,812	–	–	0.01%	641
2015 Q2	$1.5M	Buy	+72,812	New	+$1.72M	0.02%	530

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marshall Wace's IMDZ Position: Q4 2018 in Review

Marshall Wace sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 10,298 shares — an estimated $36K sold.

Marshall Wace first reported a position in IMDZ in Q2 2015 and held it in 5 quarters. The position peaked at $1.5M in Q2 2015. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

Marshall Wace reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
Marshall Wace sold 10,298 Immune Design Corp. shares in Q4 2018, an estimated $36K.
Marshall Wace first reported a position in Immune Design Corp. in Q2 2015 and held it in 5 quarters.
Marshall Wace's Immune Design Corp. position peaked at $1.5M in Q2 2015.
64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Marshall Wace's 13F filing for Q4 2018, filed 14 Feb 2019.